Russell Investments Group
SGP

Russell Investments Group’s SpyGlass Pharma SGP Stock Holding History

Russell Investments Group’s Portfolio SGP Stock Details SGP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.7K Buy
+886
New +$19.2K ﹤0.01% 3810

Other funds holding SGP

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Russell Investments Group's SGP Position: Q2 2026 in Review

Russell Investments Group opened a new position in SpyGlass Pharma (SGP) in Q2 2026: 886 shares worth $19.7K. The stake represents ﹤0.01% of the portfolio and ranks #3810 among its holdings.

43 funds tracked by Wall St. Rank hold SGP as of Q2 2026.

  • Russell Investments Group held 886 shares of SpyGlass Pharma worth $19.7K as of Q2 2026.
  • SpyGlass Pharma was a new Russell Investments Group position in Q2 2026.
  • SpyGlass Pharma made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3810 holding.
  • 43 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.